These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 18537066)

  • 21. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M; Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk factors in young, overweight, and obese European adults and associations with physical activity and omega-3 index.
    Ramel A; Pumberger C; Martinéz AJ; Kiely M; Bandarra NM; Thorsdottir I
    Nutr Res; 2009 May; 29(5):305-12. PubMed ID: 19555811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease?
    de Zeeuw D; Bakker SJ
    Nat Clin Pract Cardiovasc Med; 2008 Jul; 5 Suppl 1():S10-4. PubMed ID: 18580860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between ghrelin and the metabolic syndrome in the elderly: a longitudinal population-based study.
    Serra-Prat M; Alfaro SR; Palomera E; Casamitjana R; Buquet X; Fernández-Fernández C; Puig-Domingo M;
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):227-32. PubMed ID: 18547344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum zinc, plasma ghrelin, leptin levels, selected biochemical parameters and nutritional status in malnourished hemodialysis patients.
    Sahin H; Uyanik F; Inanç N; Erdem O
    Biol Trace Elem Res; 2009 Mar; 127(3):191-9. PubMed ID: 18953507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and cardiometabolic risk: an update.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Bombelli M; Mancia G
    Blood Press; 2009; 18(1-2):7-16. PubMed ID: 19148840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Sowers JR
    J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
    Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
    J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome: a double-edged sword.
    Park W; Kim BS; Lee JE; Huh JK; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR; Rhee EJ; Oh KW; Lee WY; Park CY; Park SW; Kim SW
    Diabetes Res Clin Pract; 2009 Jan; 83(1):119-25. PubMed ID: 19101054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial progenitor cell status in metabolic syndrome.
    Jialal I
    Metab Syndr Relat Disord; 2010 Jun; 8(3):193-5. PubMed ID: 20367241
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolic syndrome and the heart--a considered opinion.
    Leichman JG; Lavis VR; Aguilar D; Wilson CR; Taegtmeyer H
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i134-41. PubMed ID: 16598541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Smoking].
    Asano M
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():411-7. PubMed ID: 17458254
    [No Abstract]   [Full Text] [Related]  

  • 36. Groups question existence of metabolic syndrome.
    Frantz S
    Nat Rev Drug Discov; 2005 Oct; 4(10):796-7. PubMed ID: 16240468
    [No Abstract]   [Full Text] [Related]  

  • 37. The new cardiovascular continuum.
    Cheung BM
    Hong Kong Med J; 2006 Apr; 12(2):161-3. PubMed ID: 16603787
    [No Abstract]   [Full Text] [Related]  

  • 38. Spirometric findings and cardiovascular risk.
    Singh R
    Am Fam Physician; 1997 Sep; 56(4):1071. PubMed ID: 9310059
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular risk--through the ages.
    Kastelein J
    Atheroscler Suppl; 2004 May; 5(2):1-2. PubMed ID: 15121028
    [No Abstract]   [Full Text] [Related]  

  • 40. Nature's randomised trials.
    Hingorani A; Humphries S
    Lancet; 2005 Dec; 366(9501):1906-8. PubMed ID: 16325682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.